IBDoc – SwissMedtech Award Nominee

US: IBDoc® is not available for sale in the US.

Health Canada License: 98903, Device class: 3

BÜHLMANN was nominated to receive the Swiss Medtech Award for 2018 for the IBDoc® calprotectin smartphone-based rapid test   

About Swiss MEDTECH

Swiss Medtech was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative capacity, and to strengthen the domestic market.

Swiss Medtech is committed to promoting Switzerland as a leading scientific workplace and centre of research by providing targeted training and further education programmes, symposiums, export-promoting services, and supportive measures for entrepreneurship. The Association also contributes significantly to ensuring quality-oriented health care with fair reimbursement rates and advanced innovation funding for patient well-being.


IBDoc® SwissMedtech Award Nominee


At this year’s SwissMedtech Day, BÜHLMANN was nominated to receive the Swiss Medtech Award. Switzerland is listed by key rankings as the “globally most innovative country”. Medtech one of the industries heavily contributing to this ranking. Out of 25 applications BÜHLMANN Laboratories AG was chosen to present IBDoc® to a Jury of medtech and academic reperesentatives. The jury nominated 3 projects for the Swiss Medtech Award 2018, BÜHLMANN Laboratories AG among them. June 12th IBDoc® was presented to 600 attendees from the entire Swiss Medtech sector.





IBDoc® (Overview)

Watch this overview of IBDoc®  by BÜHLMANN Laboratories AG’s Dr. Jakob Weber, VP technology & Innovation and Dr. Christian Reinhard, Product Manager IBDoc®  to get an overview of the system. Visit calprotectinassays.com and ibdoc.net to explore other IBDoc® videos.